When the world's most powerful central bank speaks, even distant markets pause to listen. The Federal Reserve's decision to cut rates by a quarter point on Wednesday offered little comfort once Chair Jerome Powell suggested the easing cycle may be nearing its end — a signal that sent Indian equities lower on Thursday, with the Sensex shedding nearly 600 points and the Nifty50 slipping below 25,900. In the larger human story of capital and confidence, this is a familiar moment: relief at what was given, unease about what may not come next.
News18
· Oct 30, 2025
· economy
· 2 min de lectura
High
Verificación: Verificado
Sensex Falls 593 Points as Fed Signals End to Rate Cuts; Pharma Stocks Slide
◉
Economy & Finance
6268 artículos relacionados
Chinese robotics giant Unitree soars 600% in Shanghai debut
BBC News · 100% coincidencia
Asian shares mixed as Fed rate cut fuels Wall Street rally, but AI spe…
Japan Today · 99% coincidencia
Asian shares mixed as Wall Street nears records on Fed rate-cut hopes
Daily Excelsior · 99% coincidencia
Asian shares mixed as Wall Street nears record high amid Fed rate cut …
Daily Excelsior · 99% coincidencia
Stock market retreats as Big Tech earnings disappoint despite Trump-Xi…
The Boston Herald · 99% coincidencia
Cobertura Relacionada
The New York Times · Aug 19
The 'Crack Spread' Is Keeping Gas Prices High Despite Stable Crude
The 'crack spread'—the profit margin between crude oil and refined products—is keeping gas prices elevated despite stabl…
Lowy Institute · Aug 19 Australia can lead Physical AI testing as China, US race for robotics dominanceAs humanoid robotics converge with advanced AI, Australia can capture value by becoming a global testing and validation …
Google News · Aug 19 Trump Pauses 50% Canadian Tariffs for 3 Days Amid Last-Minute DealTrump temporarily halts threatened 50% tariffs on Canadian goods for three days following announcement of a last-minute …
CNA · Aug 19 India's graduates face uncertain futures as universities struggle to keep pace with job marketIndian universities are producing more graduates than ever, but youth unemployment remains high as the economy fails to …
Sesgo y Encuadre
⚖
Factual market reporting with neutral tone; presents Fed decision and market reactions without apparent ideological bias, though selective emphasis on negative indices.
Bias Direction
center
Confidence
MED
Event-driven reporting with emphasis on negative market movements (falls, slides, weakness) in headline and opening, balanced by inclusion of positive performers (Nasdaq, tech gains) in body text.
sharply lower
slid
weakness
caution prevailed
uncertainty
Analyst commentary on whether market decline is temporary or signals broader concerns
Retail investor sentiment or impact perspective
Indian government or RBI official response to market movements
Sector-specific analysis beyond pharma stocks mentioned in title but not detailed in body
Long-term market outlook from financial experts
Impacto Geopolítico
🌎
Fed's hawkish rate-cut signal triggers Indian market decline, reflecting broader capital flow concerns as US-China trade tensions loom amid shifting monetary policy expectations.
Escalation Risk
moderate
Confidence
HIGH
India
United States
China
Japan
Australia
Asia-Pacific
US monetary policy tightening reasserts dollar strength and capital repatriation to US markets, reducing emerging market liquidity. Simultaneous US-China trade tensions elevate uncertainty, potentially fragmenting global capital flows. India's market sensitivity to Fed signals reflects its dependence on foreign institutional investment and exposure to global risk sentiment.
Similar to 2018 Fed tightening cycle, when emerging markets experienced sharp selloffs due to capital flight; however, current tech sector resilience (Nasdaq gains) differs from 2018 patterns.
Lente Económico
📈
Fed's signal of no further 2025 rate cuts triggered Indian market selloff (Sensex -0.70%, Nifty -0.68%), with pharma stocks declining amid global caution and US-China trade uncertainty.
Market Signal
bearish
Confidence
HIGH
Pharmaceuticals
Financial Services
Information Technology
Banking
Consumer Goods
Higher borrowing costs ahead as rate cut cycle ends; reduced purchasing power for loans and mortgages; potential pressure on discretionary spending as equity portfolios decline; pharma sector weakness may affect healthcare affordability.
RBI may need to reassess its own monetary policy stance independent of Fed actions; potential fiscal stimulus measures to support domestic growth; regulatory focus on managing currency volatility and capital outflows; monitoring of US-China trade negotiations for tariff impacts on Indian exports.